Digestives & Intestinal Remedies - China

China

Highlights

In the Digestives & Intestinal Remedies market market, the revenue in China reached a staggering amount of US$4.41bn in 2024.
Looking ahead, the market is projected to experience a steady annual growth rate of 0.89% (CAGR 2024-2029).
When comparing the global market, China stands out as the top revenue generator, accounting for the same impressive figure of US$4.41bn in 2024.
This translates to a per person revenue of US$3.08 in 2024, in relation to the country's total population.
China's growing middle class and increasing awareness of digestive health are driving the demand for digestive and intestinal remedies in the OTC pharmaceuticals market.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in China has experienced significant growth in recent years, driven by changing consumer preferences and local special circumstances.

Customer preferences: Chinese consumers have become increasingly health-conscious in recent years, leading to a growing demand for digestive and intestinal remedies. This trend is driven by several factors, including an aging population, rising disposable incomes, and a greater emphasis on preventive healthcare. As consumers become more aware of the importance of digestive health, they are seeking out products that can help alleviate digestive issues and promote overall well-being.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in China is the growing popularity of natural and herbal remedies. Chinese consumers have a long history of using traditional Chinese medicine to treat various ailments, including digestive problems. As a result, there is a strong demand for products that are made from natural ingredients and have a traditional medicinal background. This trend is also driven by concerns about the safety and efficacy of synthetic drugs, as well as a desire for more sustainable and environmentally friendly options. Another trend in the market is the increasing availability of digestive and intestinal remedies through e-commerce platforms. The rise of online shopping in China has made it easier for consumers to access a wide range of products, including health supplements and remedies. This has allowed smaller, niche brands to enter the market and compete with larger, more established players. Additionally, e-commerce platforms offer a convenient and discreet way for consumers to purchase these products, which can be particularly appealing for those who are seeking treatment for sensitive or embarrassing conditions.

Local special circumstances: China's rapidly aging population is a key factor driving the growth of the Digestives & Intestinal Remedies market. As people age, they are more likely to experience digestive issues and seek out remedies to alleviate their symptoms. This demographic shift has created a significant market opportunity for companies that offer products targeting the specific needs of older consumers. Additionally, China's large population and rising middle class have also contributed to the growth of the market, as more people have the means to afford and access these products.

Underlying macroeconomic factors: China's strong economic growth has played a significant role in the development of the Digestives & Intestinal Remedies market. As disposable incomes rise, consumers have more money to spend on healthcare products, including digestive and intestinal remedies. Additionally, the Chinese government's focus on healthcare reform and improving access to healthcare services has also contributed to the growth of the market. These factors, combined with changing consumer preferences and local special circumstances, have created a favorable environment for the development of the Digestives & Intestinal Remedies market in China.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.